Learning Module - Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oiGsbc
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involve...
-
Abstract Cerebral ischemia leads to multifaceted injury to the brain. A polytherapeutic drug that can be administered immediately after re...
-
Abstract Unsaturated fatty acid biohydrogenation products from beef fat and pure fatty acids were subjected to the Ames Salmonella mutage...
-
Abstract Cerebral and systemic organ microvascular pathologies coexist with human Alzheimer’s disease (AD) neuropathology. In this study, w...
-
Grandma covered cancer with make up for months Toowoomba Chronicle In Queensland more than 740 people are diagnosed with head and nec...
-
A descriptive study of clinical and radiological profile of longitudinal extensive myelitis in a tertiary hospital in Rajasthan, India Publi...
-
Publication date: November 2017 Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume 124, Issue 5 Author(s): J...
-
Lippincott Journals Monthly Update: Otolaryngology Case Studies Comparing Learning Profiles and Response to Instruction in Autism Spectrum...
-
Abstract Background To study whether thyroid function was associated with risk of hip or knee replacement due to primary osteoarthritis....
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου